1. Home
  2. RKLB vs TEVA Comparison

RKLB vs TEVA Comparison

Compare RKLB & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Lab USA Inc.

RKLB

Rocket Lab USA Inc.

N/A

Current Price

$53.68

Market Cap

29.6B

Sector

Industrials

ML Signal

N/A

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

N/A

Current Price

$30.10

Market Cap

30.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RKLB
TEVA
Founded
2006
1901
Country
United States
Israel
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.6B
30.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RKLB
TEVA
Price
$53.68
$30.10
Analyst Decision
Buy
Strong Buy
Analyst Count
14
9
Target Price
$50.38
$30.56
AVG Volume (30 Days)
20.3M
10.5M
Earning Date
11-10-2025
01-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.62
Revenue
$554,535,000.00
$16,776,000,000.00
Revenue This Year
$40.19
$4.74
Revenue Next Year
$48.56
$0.48
P/E Ratio
N/A
$48.77
Revenue Growth
52.42
0.02
52 Week Low
$14.71
$12.47
52 Week High
$73.97
$30.44

Technical Indicators

Market Signals
Indicator
RKLB
TEVA
Relative Strength Index (RSI) 53.33 80.15
Support Level $52.68 $28.00
Resistance Level $65.18 $30.44
Average True Range (ATR) 4.14 0.65
MACD 1.36 0.07
Stochastic Oscillator 54.90 91.36

Price Performance

Historical Comparison
RKLB
TEVA

About RKLB Rocket Lab USA Inc.

Rocket Lab Corp is engaged in space, building rockets, and spacecraft. It provides end-to-end mission services that provide frequent and reliable access to space for civil, defense, and commercial markets. It designs and manufactures the Electron and Neutron launch vehicles and Photon satellite platform. Rocket Lab's Electron launch vehicle has delivered multiple satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. The business operates in two segments Launch Services and Space Systems. Geographically it serves Japan, Germany, and rest of the world and earns key revenue from the United States.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: